<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/265185-spirocyclic-ketols-and-their-use by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 03:45:16 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 265185:&quot;SPIROCYCLIC KETOLS AND THEIR USE&quot;</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">&quot;SPIROCYCLIC KETOLS AND THEIR USE&quot;</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>Described are spirocyclic ketols of formula (I) wherein n and A have the same meaning as given in the description. Also disclosed is a method for their production and flavour and fragrance compositions containing them.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>ORGANIC COMPQUNDS -&gt; SPIROCYCLIC KETOLS AND THEIR USE*<br>
 Title Changed by ISA<br>
The present invention refers to novel compounds having patchouli-like odour notes.<br>
This invention relates furthermore to a method for their production and to flavour and<br>
fragrance compositions containing them.<br>
Patchouli oil with its powerful woody-balsamic odor and well-balanced herbaceous,<br>
earthy, camphoraceous and floral facets today constitutes one of the most important<br>
natural perfumery raw materials in use. It is an essential building block especially for<br>
chypre and oriental fine fragrances, both feminine and masculine, and it is also of<br>
crucial importance in functional perfumery. Its most important olfactory constituent (-)-<br>
patchoulol, which makes up around 35-40 weight % of the essential oil, is structurally<br>
too complex to allow a synthetic approach that could compete with the price of the<br>
natural material. Thus, there is an ongoing demand in the fragrance and flavour industry<br>
for new compounds imparting, enhancing, or improving patchouli-like odour notes.<br>
We have now found a novel class of spirocyclic ketols that possesses typical patchouli<br>
odours.<br>
In a first aspect the present invention provides a compound of formula (I)<br>
OH<br>
wherein n is 0, 1,2, or 3; and<br>
ring A represents a cycloalkyl ring wherein up to 5 hydrogen atoms, i.e. none, 1, 2, 3, 4,<br>
or 5 are substituted by a methyl group; and<br>
the total number of carbon atoms of the compound of formula (I) is 11, 12, 13, 14, 15, or<br>
16.<br>
The compounds according to the present invention contain two or more stereocenters,<br>
and as such exist as mixtures of stereoisomers. They can be used as stereoisomeric<br>
mixtures, or may be resolved in diastereomerically and/or enantiomerically pure form.<br>
Resolving stereoisomers adds to the complexity of manufacture and purification of<br>
these compounds, and so it is preferred to use the compounds as mixtures of their<br>
stereoisomers simply for economic reasons. However, if it is desired to prepare<br>
individual stereoisomers, this may be achieved according to methodology known in the<br>
art, e. g. preparative HPLC and GC or by stereoselective syntheses.<br>
Particular preferred compounds of formula (I) are selected from the group consisting of<br>
(1f?*,4S*,5S*,9R*)-1-hydroxy-1,4,7,7,9-pentamethylspiro[4.5]decan-2-one,<br>
(1R*,4R*,5S*,9R*)-1-hydroxy-1,4,7,7,9-pentamethylspiro[4.5]decan-2-one, (1R*,4R*)-1-<br>
hydroxy-1,4,7,7,9,9-hexamethylspiro[4.5]decan-2-one, (1R*,4S*,5/VR*,9S*)-1-<br>
hydroxy-1,4,7,9-tetramethylspiro[4.5]decan-2-one, (1 R*,4R*,5r*, 7R*,9S*)-1 -hydroxy-<br>
1,4,7,9-tetramethylspiro[4.5]decan-2-one, and (1f?*,4S*)-1-hydroxy-1,4-<br>
dimethylspiro[4.6]undecan-2-one.<br>
It was found when the methyl groups at C-1 and C-4 are c/s-configured with respect to<br>
one another, i.e. when C-1 and C-4 are unlike configured as (\R", 4S*), the<br>
compounds of the present invention have a lower odor threshold than the compounds<br>
wherein the methyl groups at C-1 and C-4 are frans-configured. The odor threshold of<br>
the unlike isomers is up to 270 times lower. Accordingly, compounds of formula (I)<br>
wherein the methyl groups at C-1 and C-4 are c/s-configured with respect to one<br>
another are particularly preferred.<br>
The compounds according to the present invention may be used alone or in<br>
combination with known odouriferous molecules selected from the extensive range of<br>
natural and synthetic molecules currently available, such as essential oils, alcohols,<br>
aldehydes and ketones, ethers and acetals, esters and lactones, macrocycles and<br>
heterocycles, and/or in admixture with one or more ingredients or excipients<br>
conventionally used in conjunction with odourants in fragrance compositions, for<br>
example, carrier materials, and other auxiliary agents commonly used in the art.<br>
Thus, in another aspect, the invention provides fragrance compositions comprising a<br>
compound of formula (I) or a mixture thereof.<br>
The following list comprises examples of known odouriferous molecules, which may be<br>
combined with the compounds of the present invention:<br>
ethereal oils and extracts, e.g. castoreum, costus root oil, oak moss absolute,<br>
geranium oil, jasmine absolute, patchouli oil, rose oil, sandalwood oil orylang-ylang<br>
oil;<br>
alcohols, e.g. citronellol, Ebanol®, eugenol, geraniol, Super Muguet, linalool,<br>
phenylethyl alcohol, Sandalore®, terpineol orTimberol®;<br>
aldehydes and ketones, e.g. Azurone, a-amylcinnamaldehyde, Georgywood,<br>
hydroxycitronellal, Iso E Super, Isoraldeine, Hedione®, maltol, methyl cedryl<br>
ketone, methylionone or vanillin;<br>
- ether and acetals, e.g. Ambrox®, geranyl methyl ether, rose oxide or<br>
Spirambrene®;<br>
esters and lactones, e.g. benzyl acetate, cedryl acetate, y-decalactone,<br>
Helvetolide®, y-undecalactone or vetivenyl acetate;<br>
- macrocycles, e.g. ambrettolide, ethylene brassylate or Exaltolide®;<br>
heterocycles, e.g. isobutylchinoline.<br>
The compounds of the present invention may be used in a broad range of fragrance<br>
applications, e.g. in any field of fine and functional perfumery, such as perfumes,<br>
household products, laundry products, body care products and cosmetics. The<br>
compounds can be employed in widely varying amounts, depending upon the specific<br>
application and on the nature and quantity of other odouriferous ingredients. The<br>
proportion is typically from 0.001 to 40 weight percent of the application. In one<br>
embodiment, compounds of the present invention may be employed in a fabric softener<br>
in an amount of from 0.001 to 0.05 weight percent. In another embodiment, compounds<br>
of the present invention may be used in an alcoholic solution in amounts of from 0.1 to<br>
40 weight percent, more preferably between 0.1 and 5 weight percent. However, these<br>
values are given only by way of example, since the experienced perfumer may also<br>
achieve effects or may create novel accords with lower or higher concentrations.<br>
The compounds of the present invention may be employed into the fragrance<br>
application simply by directly mixing them or a fragrance composition comprising them<br>
with the fragrance application, or they may, in an earlier step be entrapped with an<br>
entrapment material such as for example polymers, capsules, microcapsules and<br>
nanocapsules, Hposomes, film formers, absorbents such as carbon or zeolites, cyclic<br>
oligosaccharides and mixtures thereof, or they may be chemically bonded to substrates,<br>
which are adapted to release the fragrant molecule upon application of an external<br>
stimulus such as light, enzyme, or the like, and then mixed with the application.<br>
Thus, the invention additionally provides a method of manufacturing a fragrance<br>
application, comprising the incorporation as a fragrance ingredient of at least one<br>
compound of formula (I).<br>
The compounds of the present invention may be prepared by epoxidation of the<br>
corresponding 4-methyl-1-methylenespiro[4.x]alkan-2-ones, which is available for<br>
example via the procedure as described by P. Kraft, R. Cadalbert, Synthesis 2002,<br>
2243-2253, followed by reduction, e.g. with lithium aluminum hydride, and oxidation of<br>
the formed secondary alcohol function. Prefered oxidation agents are pyridinium<br>
chlorochromate (PCC), Dess-Martin periodinane and dimethyl sulfoxide (Swern<br>
oxidation). Further particulars as to reaction conditions are provided in the examples.<br>
Figure 1 shows the X-ray crystal structure of (1R*,4S*,5S*,9R*)-1-hydroxy-1,4,7,7,9-<br>
pentamethylspiro[4.5]decan-2-one.<br>
The invention is now further described with reference to the following non-limiting<br>
examples.<br>
Example 1: (1R*,4S*,5S*.9R*)-1-Hvdroxv-1,4,7,7,9-pentamethvlspirof4.51decan-2-one<br>
At 0 °C, a solution of 4,7,7,9-tetramethyl-1-methylenespiro[4.5]decan-2-one (1.43 g,<br>
6.49 mmol), in CH2CI2 (10 ml) was added dropwise within 45 min. to a stirred solution<br>
of 70% 3-chloroperbenzoic acid (1.76 g, 7.14 mmol) in CH2CI2 (20 ml_). After further<br>
stirring at 0°C for 1 h, the cooling bath was removed, and the reaction mixture stirred for<br>
3 d, with an additional portion of 70% 3-chloroperbenzoic acid (1.76 g, 7.14 mmol)<br>
being added after the first and second day. The insoluble material was removed by<br>
vacuum filtration and washed with CH2CI2. The combined organic solutions were<br>
washed with 20% aq. NaHSO3, halfconc. NaHCO3l and water (50 mL), the aqueous<br>
washings again extracted with CH2CI2 (50 ml). The combined organic extracts were<br>
dried (Na2SO4) and concentrated in a rotary evaporator. The resulting residue was<br>
purified by silica-gel FC (pentane/Et20, 19:1, R,= 0.11) to provide 6,6,8,10-tetramethyl-<br>
1-oxadispiro[2.0.5.3]dodecan-12-one (930 mg, 61%).<br>
IR (ATR): v = 1753 (s, vC=O), 1457 (m, 5H-C-H), 854 (m, 6C-O-C, epoxide), 1196<br>
(vC-O-C, epoxide) cm"1. 1H NMR (CDCI3): 8 = 0.68/0.72 (2t, J= 12.5 Hz, 1 H, 7-Hax),<br>
0.83/0.84 (2d, J = 6.5 Hz, 3 H, 8-Me), 0.94-1.04 (m, 1 H, 9-Hax), 0.91/0.93 (2s, 3 H, 6-<br>
Meeq), 0.95/0.96 (2s, 3 H, 6-Meax), 1.02/1.10 (2d, J = 6.5 Hz, 3 H, 10-Me), 1.16-1.23 (m,<br>
1 H, 5-Hax), 1.31-1.98 (m, 5 H, 5-, 7-, 9-Heq, 8-, 10-H), 1.99/2.07 (dd, J= 18.5, 12.5 Hz,<br>
1 H, 11-Hb), 2.46/2.76 (dd, J= 18.5, 7.0 Hz, 1 H, 11-Ha), 2.63/2.74/2.93/2.96 (4d, J =<br>
6.5 Hz, 2 H, 2-H2). 13C NMR (CDCI3): 8 = 13.7/17.2 (2q, 10-Me), 22.9/23.0 (2q, 8-Mea)
24.4/25.2 (2d, C-8), 26.0/26.1 (2q, 6-Meeq), 31.1/34.9 (2s, C-6), 35.0/35.0 (2q, 6-Meax),<br>
35.4/40.7 (2t, C-11), 36.7/40.9 (2d, C-10), 41.2/41.6 (2s, C-4), 41.8/42.3/42.5/44.6 (4t,<br>
C-5, -9), 48.2/48.7 (2t, C-2), 50.1/50.2 (2t, C-7), 67.1/70.0 (2s, C-3), 213.7/214.9 (2s, C-<br>
12). MS (70 eV): m/z (%) = 236 (2) [M*], 220 (28) [M+ - CH3], 205 (73) [C14H21O+], 178<br>
(36)[M+-CH3-C2H2O], 163(24)[M+-C2H2O-2CH3], 150 [CnH18<br>
+], 135 (68) [CnH18<br>
- CH3], 121 (59) [CnH^- C2H5], 107 (89) [C^H^- C3H7], 83 (80) [C6Hn+], 55 (88)<br>
[C4H/], 41 (100) [C3H5<br>
+].<br>
A solution of 6,6,8,10-tetramethyl-1-oxadispiro[2.0.5.3]dodecan-12-one (580 mg, 2.45<br>
mmol) in Et2O (1.5 ml) was added dropwise with stirring at room temp, to a suspension<br>
of lithium aluminum hydride (280 mg, 7.36 mmol) in Et2O (3.0 ml_). After stirring at<br>
ambient temp, for 30 min., the reaction was quenched by careful addition of water (5.0<br>
ml_) followed by aq. 5 N HCI (5.0 ml) at 0°C. The organic layer was separated, the<br>
aqueous one extracted with Et2O (2 x 25 ml). The combined organic extracts were<br>
washed with water (25 ml) and brine (25 ml), dried (Na2SO4) and concentrated on the<br>
rotary evaporator under reduced pressure to provide the crude corresponding diol (630<br>
mg). A solution of pyridinium chlorochromate (1.06 g, 4.90 mmol) in CH2CI2 (4.0 ml_)<br>
was added at room temp, in one dash to a vigorously stirred suspension of Celite® (1.00<br>
g) in CH2CI2 (8.0 ml). Stirring was continued at this temp, for 10 min., prior to addition<br>
of the crude diol (630 mg) dissolved in CH2CI2 (4.0 ml_). After stirring for additional 30<br>
min., the insoluble material was removed by vacuum filtration through a pad of Celite®<br>
with thorough washing with CH2CI2. The organic extracts were concentrated under<br>
reduced pressure, and the resulting residue purified by silica-gel FC (pentane/Et2O, 9:1,<br>
R, = 0.46) to afford as the most intensely smelling fraction (1R*,4S*,5S*,9R*)-1-hydroxy1,4,7,7,9-<br>
pentamethylspiro-[4.5]decan-2-one (30 mg, 5%) in form of colorless crystals,<br>
mp. 73-74 °C.<br>
IR (ATR): v = 1738 (s, vC=O), 1098 (s, vC-O), 3456 (s, vO-H), 1382 (m, 8CH3) cm"1.<br>
1H NMR (C6D6): 5 = 0.31 (dd, J = 12.0, 12.0 Hz, 1 H, 10-Hax), 0.62 (dd, J = 12.0, 12.0<br>
Hz, 1 H, 8-Hax), 0.66 (d, J = 7.5 Hz, 3 H, 4-Me), 0.79 (dt, J = 14.5, 2.5 Hz, 1 H, 6-Hax),<br>
0.81 (d, J = 6.5 Hz, 3 H, 9-Meeq), 0.95 (s, 3 H, 7-Meeq), 1.00 (s, 3 H, 1-Me), 1.22 (s, 3 H,<br>
7-Meax), 1.35 (mc, 1 H, 4-Hax), 1.36 (ddt, 1 H, J- 12.0, 6.0, 2.5, 8-Heq), 1.50 (dt, J =<br>
14.5, 2.5 Hz, 1 H, 6-Heq), 1.57 (ddt, J= 12.0, 6.0, 2.5 Hz, 1 H, 10-Heq), 1.62(dd, J =<br>
20.0, 3.0 Hz, 1 H, 3-H.q), 2.27 (dd, J = 20.0, 9.5 Hz, 1 H, 3-Hax), 2.34 (mc, 1 H, 9-H),<br>
2.90 (s, 1 H, O-H). 1H,1H NOESY: 1-Me x 4-Me, 1-Me x 6-Heq, 4-Me x 6-Hax, 4-Me x 6-<br>
Heq, 7-Meax x 9-Hax. 13C NMR (C6D6): 5 = 18.4 (q, 4-Me), 23.6 (q, 9-Me), 24.1 (q, 1-Me),<br>
26.4 (d, C-9), 26.5 (q, 7-Meax), 31.6 (s, C-7), 35.2 (q, 7-Meeq), 39.6 (t, C-3), 40.6 (d, C-<br>
4), 42.0 (t, C-6), 46.0 (s, C-5), 47.8 (t, C-10), 49.2 (t, C-8), 81.3 (s, C-1), 221.2 (s, C-2).<br>
MS (70 eV): mlz (%) = 238 (4) [M+], 220 (1) [M+ - H2O], 205 (1) [M+ - H2O - CH3], 168<br>
(4) [CnHzoO*], 152 (39) [CnH20*], 137 (11) [CnH20<br>
+ - CH3], 123 (25) /109 (22) / 95 (15)<br>
[CnH(2n_3,1, 83 (100) [M*- C9H1502], 69 (13) [C5H9<br>
+], 55 (22) [C4H/], 43 (36) [C3H7*].<br>
Odor description: Strong, powerful, and characteristic of natural patchouli oil, with rich<br>
woody-ambery and tobacco-like facets<br>
Example 2: (1R*.4R*.5S*.9R*)-1-Hvdroxy-1,4.7.7.9-pentamethvlspirof4.51decan-2-one<br>
Following the procedure detailed in Example 1, 1,4,7,7,9-pentamethylspiro-[4.5]decan-<br>
1,2-diol was prepared by reduction of 6,6,8,10-tetramethyl-1-oxadispiro-<br>
[2.0.5.3]dodecan-12-onewith lithium aluminum hydride. A solution of Dess-Martin<br>
periodinane (780 mg, 1.84 mmol) in CH2CI2 (20 ml) was added in one dash to a stirred<br>
solution of 1,4,7,7,9-pentamethylspiro[4.5]decan-1,2-diol (400 mg, 1.66 mmol) in<br>
CH2CI2 (15 mL) Stirring was continued at room temperature for 6 h, prior to quenching<br>
by dropwise addition of a solution of Na2S2O3 (950 mg, 6.00 mmol) in satd. aq. NaHCO3<br>
(40 ml). After stirring for 30 min., water (50 ml) was added, the organic layer was<br>
separated, and the aqueous one extracted with CH2CI2 (50 ml). The combined organic<br>
extracts were washed with water (50 ml), dried (Na2SO4), vacuum-filtrated over a pad<br>
of Celite®, and concentrated on the rotary evaporator. The resulting residue (430 mg)<br>
was separated by repeated silica-gel FC (pentane/Et2O, 9:1, Rf = 0.48) to finally provide<br>
the weaker, less polar (1R*,4ft*,5S*,9fi*)-configured diastereoisomer of 1-hydroxy1,4,7,7,9-<br>
pentamethylspiro[4.5]decan-2-one (60 mg, 15%) in pure form as colorless<br>
crystals, mp. 72-73 °C.<br>
IR (ATR): v = 1743 (s, vC=O), 1106/1081 (s, vC-O), 3470 (s, vO-H), 1385 (m, 5CH3)<br>
cm-1. 1H NMR (CDCI3): 5 = 0.64 (t, J = 12.0 Hz, 1 H, 8-Hax), 0.72 (t, J = 12.5 Hz, 1 H,<br>
10-Hax), 0.78 (d, J = 7.0 Hz, 3 H, 9-Me), 0.94 (s, 3 H, 7-Meeq), 1.00 (d, J = 6.5 Hz, 3 H,<br>
4-Me), 1.02 (d, J= 12.5 Hz, 1 H, 10-Heq), 1.14 (s, 3 H, 3 H, 7-Meax), 1.17(s, 3 H, 1-<br>
Me), 1.20 (d,J = 14.5 Hz, 1 H, 6-Hax), 1.35 (d, J= 12.0 Hz, 1 H, 8-Heq), 1.45 (d, J = 14.5<br>
Hz, 1 H, 6-Heq), 1.82 (dd, J= 16.5, 11.0 Hz, 1 H, 3-Hb), 1.87 (mc, 1 H, 4 H), 2.16 (mc, 1<br>
H, 9-H), 2.54 (dd, J = 16.5, 6.5 Hz, 1 H, 3-Ha), 2.84 (s, 1 H, OH). 1H,1H NOESY: 1-Me x<br>
4-H, 1-Me 
14.5 (q, 4-Me), 21.4 (q, 1-Me), 23.3 (q, 9-Me), 25.3 (d, C-9), 26.3 (q, 7-Meax), 31.2 (s, C-<br>
7), 34.8 (q, 7-Meeq), 34.8 (t, C-10), 35.8 (d, C-4), 38.5 (t, C-3), 40.9 (t, C-6), 47.0 (s, C-<br>
5), 49.0 (t, C-8), 83.9 (s, C-1), 221.6 (s, C-2) ppm. MS (70 eV): m/z (%) = 238 (7) [M+],<br>
220 (1) [M* - H2O], 205 (1) [M+ - H2O - CH3], 168 (2) [Cn^oO4], 152 (40) [CnHzoL<br>
137 (12) [CnHao* - CH3], 123 (26) / 109 (22) / 95 (15) [CnH(2n_3)<br>
+]- 83 (100) [M+-<br>
C9H1502], 67 (12) [C5H7<br>
+], 55 (24) [C4H7<br>
+], 43 (37) [C3H/].<br>
Odor description: Nice, pleasant, and characteristic of natural patchouli oil, but about<br>
270 times weaker than the (1R*,4S*,5S*,9f?*)-isomer.<br>
Example 3: (1R*,4R*)-1-Hvdroxv-1,4,7.7.9,9-hexamethvlspiror4.51decan-2-one<br>
A solution of 4,7,7,9,9-pentamethyl-1-methylenespiro[4.5]decan-2-one (19.0 g, 81.1<br>
mrnol), in CH2CI2 (250 ml) was added dropwise at 0 °C during 2 h to a stirred solution<br>
of 70% 3-chloroperbenzoic acid (40.0 g, 162 mmol) in CH2CI2 (500 ml). The cooling<br>
bath was removed after stirring for 2 h at 0 °C, and stirring was continued for 5 d at<br>
room temp., with an additional portion of 70% 3-chloroperbenzoic acid (40.0 g, 162<br>
mmol) being added after the second and forth day. The reaction mixture was then<br>
vacuum filtered over a pad of Celite®, and poured into ice-cold aq. 20% NaHSO3 (1L).<br>
The formed precipitate was removed by vacuum filtration over Celite® and washed<br>
thoroughly with CH2CI2. Water (200 mL) was added to the filtrate and pH 8 was<br>
adjusted by addition of satd. aq. Na2CO3 (ca. 200 mL). The organic layer was separated<br>
and washed with water (500 mL), the aqueous layer extracted with CH2CI2 (500 mL).<br>
The combined organic extracts were dried (Na2SO4) and the solvent removed on the<br>
rotary evaporator. The resulting residue (18.8 g) was purified by silica-gel FC<br>
(pentane/Et2O, 19:1, R, = 0.11) to provide (3f?*,10S*)-6,6,8,8,1O-pentamethyl-1-<br>
oxadispiro[2.0.5.3]dodecan-12-one (5.89 g, 29%).<br>
IR (ATR): v = 1751 (s, vC=O), 1367 (s, 5CH3), 852 (m, 5C-O-C, epoxide), 1458 (m,<br>
8H-C-H) cm'1. 1H NMR (CDCI3): 5 = 0.60 (d, J = 15.0 Hz, 1 H, 11-Hax), 0.92/0.96 (2s, 6<br>
H, 6-,8-Me.x), 1.00 (d, J= 14.0 Hz, 1 H, 5-Hax), 1.08 (d, J = 7.0 Hz, 3 H, 10-Me), 1.10(d,<br>
J= 14.0 Hz, 1 H, 7-Hax), 1.14/1.17(2s, 6 H, 6-,8-Meeq), 1.34 (dt, J = 14.0, 1.5 Hz, 1 H,<br>
7-Heq), 1.59(dt, J=15.0, 1.5 Hz, 1 H, 11-Heq), 1.69 (dt, J= 14.0, 1.5 Hz, 1 H, 5-Heq),<br>
2.11 (dd, J = 18.5, 2.0, 1 H, 9-Hax), 2.70 (d, J = 5.5 Hz, 1 H, 2-Hb), 2.77 (dd, J = 18.5,<br>
7.0, 1 H, 9-Heq), 2.84 (quint, d, J = 7.0, 2.0 Hz, 1H, 10-H), 3.00 (d, J = 5.5 Hz, 1 H, 2-<br>
Ha). 13C NMR (CDCI3): 5 = 17.8 (q, 10-Me), 29.7 (2q, 6-,8-Meeq), 30.7/31.5 (2s, C-6,-8),<br>
35.3 (d, C-10), 35,7 (2q, 6-,8-Meax), 36.5 (t, C-11), 42.6 (s, C-4), 43.4/45.1 (2t, C-5, -9),<br>
47.1 (t, C-2), 51.7 (t, C-7), 66.7 (s, C-3), 215.1 (s, C-12). MS (70 eV): m/z (%) = 250 (2)<br>
[M*], 234 (11) [M+ - O], 219 (100) [M+ - O - CH3], 208 (6) [M+ - C3H6], 205 (7) [M+ - O -<br>
C2H5], 193 (29) [M* - O - C3H5], 164 (22) [CnH^Ol, 149 (52) [CnH16O+ - CH3], 121<br>
(50) [CnH160+ - C3H7], 91 (54) [C7H/], 79 (50) [C6H/], 55 (48) [C4H7<br>
+], 41 (60) [C3H6<br>
Under N2 atmosphere, a solution of (3f?*,10S*)-6,6,8,8,10-pentamethyl-1-oxadispiro-<br>
[2.0.5.3]dodecan-12-one (5.65 g, 22.6 mmol) in Et2O (10 ml) was added dropwise<br>
within 20 min. to a stirred suspension of lithium aluminum hydride (1.29 g, 33.8 mmol)<br>
in Et2O (25 ml) The reaction mixture was refluxed for 3 h, and then stirred at room<br>
temp, over night, prior to quenching at 0 °C by addition of water (20 ml), followed by<br>
aq. HCI (5 N, 20 ml). The organic layer was separated, the aqueous one extracted with<br>
Et20 (2x50 mL). The combined organic extracts were washed with water (50 ml) and<br>
brine (25 mL), dried (Na2SO4) and concentrated on the rotary evaporator. The resulting<br>
residue was purified by silica-gel FC (pentane/Et2O, 4:1, f?t = 0.10) to provide<br>
(1R*,2S*,4R*)-1,4,7,7,9,9-hexamethylspiro[4.5]decane-1,2-diol (4.82 g, 84%).<br>
IR (ATR): v = 1098/1075 (s, vC-O), 1366 (m, 6CH3), 3411 (m, vO-H) cm"1. 1H NMR<br>
(C6D6): 8= 0.91/0.97 (s, 6 H, 7-,9-Meax), 0.93 (mc, 2 H, 6-H2), 0.94 (s, 3 H, 1-Me), 1.02<br>
(d, 13.0 Hz, 1 H, 8-Hax), 1.03/1.07 (s, 6 H, 7-,9-Meax), 1.09 (d,J= 15.0 Hz, 1 H, 10-Hax),<br>
1.17(d, J= 13.0 Hz, 1 H, 8-Heq), 1.19(ddd, J= 14.0, 6.0, 4.5 Hz, 1 H, 3-Hb), 1.24 (d, J<br>
= 7.5 Hz, 3 H, 4-Me), 1.44 (d, J = 6.5 Hz, 1 H, 2-OH), 1.78 (d, J = 15.0 Hz, 1 H, 10-Heq),<br>
1.81 (s, 1 H, 1-OH), 2.11 (mc, 1 H, 4-H), 2.31 (dt, J = 14.0, 9.0 Hz, 1 H, 3-Ha), 3.59 (dt, J<br>
= 9.0, 6.5 Hz, 1 H, 2-H). 1H,1H NOESY: 1-OH x10-Hax, 1-OH x 4-Me, 4-Me x 10-Heq, 1-<br>
Me x 2-H, 2-H 
21.4 (q, 4-Me), 21.7 (q, 1-Me), 30.2/30.6 (2q, 7-,9-Meax), 36.3/43.5 (2t, C-6,-10),<br>
36.6/37.0 (2q, 7-,9-Meeq), 38.3 (d, C-4), 40.7 (t, C-3), 49.7 (s, C-5), 51.8 (t, C-8), 77.0<br>
(d, C-2), 84.0 (s, C-1) ppm. MS (70 eV): m/z (%) = 254 (32) [M4], 236 (2) [M+ - H2O],<br>
221 (8) [M+ - H2O - CH3], 203 (11) [M+ - 2H2O - CH3], 191 (22) [C14H23<br>
+], 166 (46)<br>
[C12H22<br>
+], 151 (28) [C12H22<br>
+- CH3], 137 (54) /123 (39) /109 (61) [CnH(2n_3)<br>
+], 97 (90)<br>
[C7H13<br>
f], 87 (31) [C4H702<br>
+], 69 (63) [C5H9<br>
+], 55 (68) [C4H7<br>
+], 43 (100) [C3H/].<br>
Under N2 atmosphere with rigorous exclusion of moisture, a solution of dimethyl<br>
sulfoxide (340 mg, 4.40 mmol) in CH2CI2 (1 mL) was injected via syringe at -70 °C<br>
within 5 min. into a stirred oxalyl chloride solution in CH2CI2 (2 M, 1.10 ml, 2.20 mmol)<br>
diluted with CH2CI2 (5 mL). After stirring at this temp, for 5 min., (1f?*,2S*,4f?*)-<br>
1,4,7,7,9,9-hexamethylspiro[4.5]decan-1,2-diol (510 mg, 2.00 mmol) dissolved in<br>
CH2CI2 (1 mL) was injected during 5 min dropwise via syringe. Stirring was continued at<br>
-70 °C for 30 min., prior to injection of Et3N (1.01 g, 10.0 mmol). The cooling bath was<br>
removed, and the reaction mixture allowed to warm to room temp., prior to pouring into<br>
water (50 mL). The organic layer was separated, the aqueous one extracted with<br>
CH2CI2 (2x50 mL). The combined organic extracts were washed with water (50 mL),<br>
dried (Na2SO4), and concentrated on the rotary evaporator. Purification of the resulting<br>
residue by two silica-gel FC (pentane/Et2O, 19:1, f?f = 0.17) furnished (1f?*,4f?*)-1-<br>
hydroxy-1,4,7,7,9,9-hexamethylspiro[4.5]decan-2-one (330 mg, 65%).<br>
IR (ATR): v = 1741 (s, vC=O), 1362/1381 (m, 8CH3), 1066/1164/1128 (s, vC-O), 3468<br>
(s, vO-H) cm'1. 1H NMR (CDCI3): 6 = 0.96-1.18 (m, 3 H, 8-Hax,10-H2), 0.91/0.99 (2s, 6<br>
H, 7-,9-Meeq), 1 02/1.11 (2s, 6 H, 7-,9-Meax), 1.07 (d, J = 6.5 Hz, 3 H, 4-Me), 1.21 (s, 3<br>
H, 1-Me), 1.33(d, J= 13.0 Hz, 1 H, 8-Heq), 1.35 (d, J= 14.5 Hz, 1 H, 6-Hax), 1.55 (d,J =<br>
14.5 Hz, 1 H, 6-Heq), 1.82 (dd, J= 19.5, 10.0 Hz, 1 H, 3-Hb), 2.04 (mc, 1 H, 4-H), 2.48<br>
(dd, J = 19.5, 9.0 Hz, 1 H, 3-Ha), 2.86 (s, 1 H, OH). 13C NMR (CDCI3): 8 = 14.7 (q, 4-<br>
Me), 20.3 (q, 1-Me), 29.6/31.1 (2s, C-7,-9), 31.6/32.7/34.1/34.4 (4q, 7-,9-Me2),<br>
33.6/37.5/38.8 (3t, C-3,-6,-10), 35.8 (d, C-4), 47.6 (s, C-5), 49.2 (t, C-8), 83.9 (s, C-1),<br>
220.6 (s, C-2) ppm. MS (70 eV): m/z (%) = 252 (7) [M*], 237 (1) [M+ - CH3], 219 (1) [M+<br>
- CH3- H2O], 191 (3) [C14H23<br>
+], 182 (4) [C12H22O+], 166 (66) [C12H22<br>
+], 151 (39) [C12H22<br>
+<br>
- CH3], 137 (40) /123 (23) / 109 (37) [CnH(2n_3)<br>
+], 97 (100) [C7H13<br>
+], 55 (41) [C4H/], 43<br>
(72) [C3H/]. C,6H2BO2 (252.4): calcd. C 76.14, H 11.18; found C 76.18, H 11.13.<br>
Odor description: Woody, patchouli.<br>
Example 4:<br>
A)(1f?*.4S*.5/",7R*.9S*)-1-Hvdroxv-1.4,7.9-tetramethvlspiror4.51decan-2-one<br>
As described in Example 3, (4/;?*,5rt,7R*,9S*)-4,7,9-trimethyl-1-methylenespiro[4.5]-<br>
decan-2-one (5.21 g, 25.3 mmol), was reacted with 70% 3-chloroperbenzoic acid (2x<br>
8.72 g, 2x 50.5 mmol) in CH2CI2 (75 mL + 150 ml) at room temp, for 4 d. Work-up with<br>
aq. 20% NaHS03 (200 ml) and purification by silica-gel FC (pentane/Et2O, 9:1, /?f =<br>
0.22) provided 6,8,10-trimethyl-1-oxadispiro[2.0.5.3]dodecan-12-one (2.12 g, 38%).<br>
IR (ATR): v = 1751 (s, vC=0), 1456 (s, 8H-C-H), 865 (m, 5C-O-C, epoxide), 1367 (m,<br>
5CH3) cm"1. 1H NMR (CDCI3): S = 0.41/0.44 (2 pseudo q, J = 12.5 Hz, 1 H, 11-Hax),<br>
0.83/0.85/0.86/0.87 (4d, J = 9.0, 6 H, 6-,8-Me), 0.90-2.13 (m, 8 H, 6-,8-,9-Hax, 5-,7-H2,<br>
11-Haq), 1.04/1.09 (2d, J=7.0Hz, 3 H, 10-Me), 2.70/2.74 (2dd, J = 18.5, 9.0 Hz, 1 H, 9-<br>
Heq), 2.77-2.95 (m, 1 H, 10-H), 2.82/2.82 (2d, J = 6.5 Hz, 1 H, 2-Hb), 2.96/2.97 (2d, J =<br>
6.5 Hz, 1 H, 2-Ha). 13C NMR (CDCI3): S = 13.8/16.9 (q, 10-Me), 22.8/22.9/22.9/23.0 (4q,<br>
6-,8-Me), 27.4/27.5/27.6/28.3 (4d, C-6,-8), 35.5/38.6/40.7/41.0/42.2/43.2 (6t, C-5,-9,-<br>
11), 43.5/43.7 (2t, C-7), 36.7/38.6 (d, C-10), 40.6/40.8 (2s, C-4), 48.6/49.1 (t, C-2),<br>
66.9/69.7 (2s, C-3), 213.8/214.9 (2s, C-12). MS (70 eV): m/z (%) = 222 (4) [M+], 207 (7)<br>
[M+-CH3], 189 (33) [M+-CH3-H2O], 165 (38) [CnH17O+], 149(23) [CnH17<br>
+], 136(39)<br>
[C10H16"1, 121 (38) [C9H131, 107 (71) [C8Hnl 95 (71) [C7H^], 79 (70) [C6H7<br>
+], 55 (80)<br>
[C4H71,41(100)[C3H51.<br>
6,8,10-Trimethyl-1-oxadispiro[2.0.5.3]dodecan-12-one (2.11 g, 9.49 mmol) was reduced<br>
with lithium aluminum hydride (530 mg, 14.2 mmol) in refluxing Et2O (5 mL + 10 ml) for<br>
90 min. Quenching with water (10 mL) and aq. HCI (5 N, 10 mL), usual extraction and<br>
purification by silica-gel FC (pentane/Et2O, 2:1, R, = 0.20) furnished (4R*,5r*,7R*,9S*)-<br>
1,4,7,9-tetrarnethylspiro[4.5]decan-1,2-diol (1.88g, 88%).<br>
IR (ATR): v = 1455 (s, 8H-C-H), 1074/1049 (S, vC-O), 1374 (m, 8CH3), 3397 (m, vOH)<br>
crrf1. 1H NMR (C6D6): 8= 0.40 / 0.40 / 0.43 (3dd, J= 12.0, 12.0 Hz, 1 H, 10-Hb),<br>
0.62-1.43 fm, 14 H, 3-Hbl 6-,8-H2, 4-,7-,9-Me), 1.13/1.23/1.33 (3s, 3 H, 1-Me), 1.62-<br>
2.23 (m, 6 H, 2-OH, 4-,7-,9-H, 3-,10-Ha), 2.74 (br. s, 1 H, 1-OH), 3.95/3.97/3.60 (3dd, J<br>
= 8.0, 6.0 Hz, 1 H, 2-H). 13C NMR (C6D6): 5 = 14.5/15.2/15.8 (3q, 4-Me), 21.4/23.1/23.3<br>
(3q, 1-Me), 23.4/23.4/23.5/23.6/25.3/25.4 (6q, 7-,9-Me), 28.2/28.7/28.8/28.9/29.0/29.1<br>
(6d, C-7,-9), 34.9/35.1/38.4/38.6/38.8/39.1 (6t, C-6,-10), 39.2/39.9/40.3 (3d, C-4),<br>
41.3/43.5/43.9/44.1/44.4/65.8 (6t, C-3,-8), 46.7/47.5/49.0 (3s, C-5), 77.4/77.5/79.1 (3d,<br>
C-2), 81.3/81.8/84.0 (3s, C-1) ppm. MS (70 eV): m/z (%) = 226 (13) [M*], 208 (5) [M+ -<br>
H2O], 193(2)[M+-H2O-CH3], 175 (3) [M+- 2H2O - CH3], 150 (10) [M+- 2H20 -<br>
2CH3], 138 (47) [C10H18<br>
+], 109 (100) [C8H13<br>
+], 95 (37) [C7Hn+], 81 (37) [C6H9<br>
+], 55 (48)<br>
[C4H/], 43(61 )[C3H/].<br>
Under N2 atmosphere with rigorous exclusion of moisture, a solution of dimethyl<br>
sulfoxide (680 mg, 8.80 mmol) in CH2CI2 (2 ml) was injected at -75 °C within 5 min.<br>
into a stirred oxalyl chloride solution in CH2CI2 (2 M, 2.20 ml, 4.40 mmol) diluted with<br>
CH2CI2 (10 ml). After stirring at this temp, for 5 min., (4R*,5A*,7R*,9S*)-1,4,7,9-<br>
tetramethylspiro[4.5]decan-1,2-diol (910 mg, 4.00 mmol) dissolved in CH2CI2 (2 ml)<br>
was injected during 5 min dropwise via syringe. Stirring was continued at-70 °C for 15<br>
min., prior to quenching with Et3N (2.02 g, 20.0 mmol). The reaction mixture was<br>
allowed to warm to room temp., and poured into water (50 mL). The organic layer was<br>
separated, the aqueous one extracted with CH2CI2 (2 x 50 mL). The combined organic<br>
extracts were washed with water (50 mL), and dried (Na2SO4). After removal of the<br>
solvent on a rotary evaporator, the resulting residue was purified by silica-gel FC<br>
(petane/Et2O, 9:1, R, = 0.12) to provide (1K*I4S*l5/*,7R*,9S*)-1-hydroxy-1l4,7,9-<br>
tetramethylspiro[4.5]decan-2-one (530 mg, 59%).<br>
IR (ATR): v = 1732 (s, vC=O), 3428 (s, vO-H), 1063/1089 (s, vC-O), 1359 (m, 8CH3)<br>
cm'1. 1H NMR (CDCI3):S = 0.46 (pseudoq, J= 12.0 Hz, 1 H, 8-Hax), 0.74 (dq, J= 13.5,<br>
12.5 Hz, 1 H, 6-H.x), 0.83/0.88 (2d, J = 6.5Hz, 6 H, 7-,9-Me), 0.91 (dd, J = 13.5, 13.5<br>
Hz, 1 H, 10-H.x), 1.05 (d, J=7.5Hz, 3 H, 4-Me), 1.29 (s, 3 H, 1-Me), 1.41 (dq, 13.5,2.0<br>
Hz, 1 H, 10-Heq), 1.67 (mc, 1 H, 9-Hax), 1.69 (dq, 12.0, 2.0 Hz, 1 H, 8-Heq), 1.82 (dq, J<br>
= 11.5, 2.0 Hz, 1 H, 6-Heq), 1.91 (mc, 1 H, 7-Hax), 1.96 (dd, J= 19.0, 8.0 Hz, 1 H, 3-Hb),<br>
2.09 (ddq, J = 7.5, 7.5, 7.5 Hz, 1 H, 4-H), 2.26 (s, 1 H, O-H), 2.57 (dd, J = 19.0, 9.0 Hz,<br>
1 H, 3-Ha). 'H,1H NOESY: 1-Me x 4-Me, 1-Me x10-Hax, 1-Me x 10-Heq, 1-Me x 9-Hax, 4-<br>
H x 6-Hax. 13C NMR (CDCI3): 8 = 15.8 (q, 4-Me), 22.7 (q, 1-Me), 23.2/23.3 (2q, 7-,9-Me),<br>
28.4 (d, C-9), 29.0 (d, C-7), 35.8 (t, C-10), 37.4 (d, C-4), 40.5 (t, C-3), 41.1 (t, C-6), 43.8<br>
(t, C-8), 46.7 (s, C-5), 81.2 (s, C-1), 219.6 (s, C-2). MS (70 eV): m/z (%) = 224 (14) [M+],<br>
206 (3) [M4 - H2O], 191 (2) [M+-H2O-CH3], 154 (12) [C10H18O+], 138 (60) [C10H18<br>
123 (19) /109 (100) / 95 (27) [CnH(2n_3)<br>
+], 81 (29) [C6H9<br>
+], 69 (21) [C5H9<br>
+], 55 (29)<br>
[C4H/], 43(51 )[C3H/].<br>
Odor description: Typical patchouli odor.<br>
B)(1ff*.4ff*.5/*.7ff*.9S*)-1-Hvdroxv-1.4.7.9-tetramethvlspirof4.51decan-2-one<br>
Besides (1/?*,4S*,5/*,7R*,9S*)-1-hydroxy-1,4,7,9-tetramethylspiro[4.5]decan-2-one, the<br>
silica-gel FC (petane/Et2O, 9:1, Rf = 0.27) of Example 4A also furnished<br>
(1/?*,4/?*l5/*,7/?*,9S*)-1-hydroxy-1,4,7l9-tetramethylspiro[4.5]decan-2-one(220mg,<br>
25%).<br>
IR (ATR): v = 1744 (s, vC=O), 1095/1119 (m, vC-O), 1371 (m, 5CH3), 3487 (m, vO-H)<br>
cnrT1 1H NMR (CDCI3): S = 0.41 (pseudo q, J= 12.0 Hz, 1 H, 8-Hax), 0.79/0.88 (2d, J =<br>
6.5 Hz, 6 H, 7-,9-Me), 0.81 (dd, J = 13.5, 13.5 Hz, 1 H, 6-Hax), 0.98 (dd, J = 13.5, 13.5<br>
Hz, 1 H, 10-H.x), 1.01 (d, J=7.0Hz, 3 H, 4-Me), 1.08 (dq, J= 15.5, 2.0 Hz, 1 H, 6-Heq),<br>
1.17 (s, 3 H, 1-Me), 1.55 (dq, 13.5, 2.0 Hz, 1 H, 10-Heq), 1.68 (dq, 12.0, 2.0 Hz, 1 H, 8-<br>
Heq), 1.77 (mc, 1 H, 9-Hax), 1.85 (dd, J= 19.0, 11.0 Hz, 1 H, 3-Hb), 1.93 (mc, 1 H, 4-H),<br>
2.23 (mc, 1 H, 7-Hax), 2.53 (dd, J = 19.0, 8.5 Hz, 1 H, 3-Ha), 2.76 (s, 1 H, 1 O-H). 1H,1H<br>
NOESY: 4-Me x 3-H, 1-Me x 4-Me, 1-Me x 6-Heq, 4-Me x 10-Hax. 13C NMR (CDCI3): 8 =<br>
14.3 (q, 4-Me), 21.3 (q, 1-Me), 22.9/23.4 (2q, 7-,9-Me), 28.0 (d, C-9), 28.5 (d, C-7), 34.8<br>
(t, C-6), 35.3 (d, C-4), 38.7 (t, C-10), 38.9 (t, C-3), 44.1 (t, C-8), 47.1 (s, C-5), 84.5 (s, C-<br>
1), 221.1 (s, C-2). MS (70 eV): rn/z (%) = 224 (15) [M+], 206 (2) [M+ - H2O], 191 (1) [M+<br>
~ H2O - CH3], 154 (10) [C10Hi8O+], 138 (60) [C10H18<br>
+], 123 (19) /109 (100) / 95 (26)<br>
[CnH(2nV], 81 (29) [C6H9<br>
+], 67 (22) [C5H7<br>
+], 55 (28) [C4H/], 43 (53) [C3H/].<br>
Odor description: Patchouli-like, woody odor.<br>
Example 5: (1R*,4S*)-1-Hydroxv-1.4-dimethylspiro[4.61undecan-2-one<br>
Following the same general procedure of Example 3, 4-methyl-1-<br>
methylenespiro[4.6]undecan-2-one (5.29 g, 27.5 mmol) was reacted with 70% 3-<br>
chloroperbenzoic acid (13.6 g, 55.0 mmol) in CH2CI2 (75 ml + 150 ml) at room temp,<br>
for 4 d, with additional portions of 70% 3-chloroperbenzoic acid (7.00 g, 28.4 mmol)<br>
13<br>
being added after every day. Work-up with aq. 20% NaHSO3 (250 ml) and purification<br>
by silica-gel FC (pentane/Et2O, 9:1, R,= 0.19) provided (3f?*, 11S*)-11 -methyl-1-<br>
oxadispiro[2.0.6.3]tridecan-13-one(1.01 g, 18%), besides the (3R*, 11 R*)-diastereomer<br>
(Rf = 0.14, 820 mg, 14%).<br>
IR (ATR): v = 1749 (s, vC=O), 1460 (s, 5H-C-H), 830 (m, 5C-O-C, epoxide), 1381 (m,<br>
5CH3)crrf1. 1H NMR (CDCI3): 5 = 1.05 (d, J= 7.0 Hz, 3 H, 11-Me), 1.35-1.66 (m, 12 H,<br>
5-H2-10-H2), 1,99 (dd, J= 19.0, 3.0 Hz, 1 H, 12-Hb), 2.37 (dqd, J = 7.5, 7.0, 3.0 Hz, 1 H,<br>
11-H), 2.63 (dd, J = 19.0, 7.5 Hz, 1 H, 12-Ha), 2.93 (d, J = 6.5 Hz, 1 H, 2-Hb), 2.98 (d, J<br>
= 6.5 Hz, 1 H, 2-Ha). 13C NMR (CDCI3): 5 = 17.5 (q, 11-Me), 22.7/23.0 (2t, C-6,-9),<br>
30.1/30.6/31.2/35.8 (4t, C-5,-7,-8,-10), 35.5 (d, C-11), 43.1 (s, C-4), 51.6 (t, C-2), 67.5<br>
(s, C-3), 215.3 (s, C-13). MS (70 eV): mlz (%) = 208 (2) [M+], 192 (10) [C13H20O+], 177<br>
(9) [C13H200+- CH3], 164 (17) [C13H20O+- CO], 150 (24) [CnH18<br>
+], 135 (17) [CnH18<br>
CH3], 122 (51) [CnHm* - C2H4], 107 (46) [CaH,/], 93 (65) [C7H9<br>
+], 79 (100) [C6H7<br>
+], 67<br>
(41) [C5H/], 41 (50) [C3H5<br>
 (3f*,11S*)-11-Methyl-1-oxadispiro[2.0.6.3]tridecan-13-one (800 mg, 3.84 mmol) was<br>
reduced with lithium aluminum hydride (440 mg, 11.5 mmol) in Et2O (2 ml_ + 4 ml_) at<br>
ambient ternp. for 16 h. Quenching with water (5 mL) and aq. HCI (5 N, 5 mL), usual<br>
extraction and purification by silica-gel FC (pentane/Et2O, 2:1, R, = 0.16) furnished<br>
(1R*,2R*,4S*)-/(1*,2S*,4S*)-1,4-dimethylspiro[4.6]undecane-1,2-diol (620 mg, 76%).<br>
IR (ATR): v = 1076/1049 (s, vC-O), 1455/1474/1444 (s, 5H-C-H), 1377 (m, 5CH3),<br>
3388 (m, vO-H) cm"1. 1H NMR (C6D6): 5 = 0.84/0.91 (2d, J = 7.0 Hz, 3 H, 4-Me),<br>
1.06/1.09 (2s, 3 H, 1-Me), 1.07-2.15 (m, 16 H, 1-,2-OH, 3-H2, 6-H2-11-H2), 1.94/2.29<br>
(2mc, 1 H, 4-H), 3.58 (dt, J = 10.0, 5.0 Hz)/3.60 (t, J = 7.0 Hz, 1 H, 2-H). 13C NMR<br>
(C6D6): 8 = 15.7/16.3 (2q, 4-Me), 20.1/21.2 (2q, 1-Me), 24.8/25.0/25.1/25.2 (4t, C-7,-10),<br>
29.1/30.0/32.5/32.8/32.9/33.0/33.2/35.7 (8t, C-6,-8,-9,-11), 39.5/40.5 (2t, C-3),<br>
41.0/41.3 (2d, C-4), 50.0/51.4 (2s, C-5), 75.9/79.8 (2d, C-2), 82.9/84.9 (2s, C-1) ppm.<br>
MS (70 eV): mlz (%) = 212 (12) [M+], 194 (4) [M+- H20]; 192 (2) [M+- H2O - H2], 179<br>
(4) [M+- H20 - CH3], 167(5)[M+-C2H50], 149 (22) [Cn^/], 136 (17) [C10H16<br>
+], 124<br>
(92) [C9H16<br>
+], 109 (20) [C9H16<br>
+ - CH3], 107 (28) [C10H16<br>
+ - C2H5], 95 (100) [C^/], 87<br>
(36) [C4H702<br>
+], 81 (96) [C6H9<br>
+], 74 (49) [C3H6O2<br>
+], 67 (79) [C5H7<br>
+], 55 (92) [C4H7<br>
+], 43<br>
(100)[C3H/].<br>
As described in Example 1, (1R*,2R*,4S*)-/(1R*,2S*,4S*)-1,4-dimethylspiro[4.6]-<br>
undecane-1,2-diol (570 mg, 2.69 mmol) was oxidized with pyridinium chlorochromate<br>
(630 mg, 2.95 rnmol) on Celite® (630 mg) in CH2CI2 (10 + 12 ml) at room temp, for 12h.<br>
Standard work-up by vacuum filtration over a pad of Celite®furnished after purification<br>
by silica-gel FC (pentane/Et2O, 9:1, /?, = 0.10) (1ft*,4S*)-1-hydroxy-1,4-<br>
dimethylspiro[4.6]undecan-2-one (21 mg, 4%).<br>
IR (ATR): v = 1733 (s, vC=O), 1100/1059 (s, vC-0), 3429 (s, vO-H), 1382 (m, 5CH3)<br>
cm'1. 1HNMR(CDCI3):8= 1.14 (d, J= 7.0 Hz, 3 H, 4-Me), 1.24 (s, 3 H, 1-Me), 1.26-<br>
1.65(m, 12H,6-H2-11-H2), 1.93(dd, J= 19.5, 8.0 Hz, 1 H, 3-Hb), 2.08 (s, 1 H, O-H),<br>
2.32 (ddq, J = 9.5, 8.0, 7.0 Hz, 1 H, 4-H), 2.54 (dd, J = 19.5, 9.5 Hz, 1 H, 3-Ha). 1H,1H<br>
NOESY: 1-Me x 4-Me, 3-Hb x 4-Me, 1-Me x 3-Hb. 13C NMR (CDCI3): 6 = 16.9 (q, 4-Me),<br>
20.5 (q, 1-Me), 23.9/24.3 (2t, C-7,-10), 29.0/31.8/31.9/35.2 (4t, C-6,-8,-9,11), 37.0 (d, C-<br>
4), 40.7 (t, C-3), 48.6 (s, C-5), 82.3 (s, C-1), 219.1 (s, C-2). MS (70 eV): m/z (%) = 210<br>
(16) [M+], 192(3)[M+-H2O], 177 (3) [M+- H2O - CH3], 124 (99) [C9H16<br>
+], 109(13)<br>
[C8H13<br>
+], 95 (100) [C7Hn+], 81 (66) [C6H9<br>
+], 67 (55) [C5H7<br>
+], 55 (45) [C4H/], 43 (77)<br>
[C3H/].<br>
Odor description: woody, herbaceous, camphor.<br>
Example 6:<br>
The following compound may also be prepared according to the general procedure as<br>
decriped in Example 1: (1R*, 4S*, 5S*)-1-hydroxy-1,4,7,7-tetramethylspiro[4.5]decan-2-<br>
one and (1f?*, 4R*, 5S*)-1-hydroxy-1,4,7,7-tetramethylspiro[4.5]decan-2-one.<br>
Example 7: X-Rav Crystal Structure of (1f?*.4S*,5S*.9R*)-1-Hvdroxy-1,4.7,7.9-<br>
pentamethvlspiro[4.51decan-2-one (Fig. 1)<br>
Crystal data and structure refinement: Empirical formula C15H26O2, molecular mass<br>
238.36, crystal dimensions 0.5 x 0.4 x 0.01 mm, temperature 150 K, wavelength<br>
0.71073 A, triclinic crystal system, space group P-1, unit cell dimensions a =<br>
9.6129(19) A, b = 13.368(3) A, c= 13.402(3) A, a = 112.17(3)°, p = 104.57(3)°, y =<br>
103.52(3)°, V= 1436.1(5) A3, Z = 4, p= 1.102 mg m"3, M(MoKa) = 0.071 mrrf1, F(OOO)<br>
528, 6 range 2.35-26.00°, limiting indices-11 7Sl1,-16
It)<br>
reflections collected 10964, symmetry-independent reflections 5162, Rint= 0.0283,<br>
refinement full-matrix least squares on F2, data 5162, parameters 319, goodness-of-fit<br>
on F2 0.877, final R indices [l&gt;2cr(l)], R-, = 0.0392, wR2 = 0.0861, R indices (all data) R,<br>
= 0.0711, wR2 = 0.0945, Ap (max, min) = 0.265, -0.124 e A~3. C15H26O2 (238.4): calcd.<br>
C 75.58, H 10.99; found C 75.56, H 10.99.<br>
Example 8: Fruity-Floral Chypre Feminine Fine Fragrance<br>
Ingredient Parts per weight<br>
13. Iso E Super (2,3,8,8-tetramethyM,2,3,4,5,6,7,8-octahydro-2-naphthalenyl<br>
methyl ketone and isomers) 300<br>
14. Methyl dihydrojasmonate 3400<br>
15. 2-Phenylethanol 200<br>
16. 1-Phenylethyl acetate 50<br>
17. 1,13-Tridecanedioic acid ethylene ester 1000<br>
18. y-Undecalactone 5<br>
19. Vanillin 50<br>
20. (1/?*,4S*,5S*,9R*)-1-Hydroxy-1,4,7,7,9-pentamethyl-spiro[4.5]decan-2-one<br>
@ 10% in dipropylene glycol 1000<br>
Total: 10'000<br>
 (1/:?*,4S*,5S*,9f?*)-1-Hydroxy-1,4,7,7,9-pentamethylspiro[4.5]decan-2-one<br>
confers to this modern floral-fruity feminine fine fragrance body, warmth and depth, and<br>
a typical patchouli character that blends well with the rosy elements of this composition<br>
and gives the fragrance a twist in the chypre direction. In comparison with the same<br>
amount of patchouli oil, the new material has a stronger olfactory impact on the overall<br>
composition, and makes the top note less camphoraceous, while providing the same<br>
warmth, sensuality, and balsamic effect at less dosage.<br>
Example 9: Leathery-woody Masculine Perfume<br>
Ingredient Parts per weight<br>
1. Bales Roses CO2 extract 20<br>
2. Benzyl salicylate 1000<br>
3. Bergamot oil (Italy) 100<br>
4. Carrot seed oil 10<br>
5. Cedarwood oil (Atlas) 20<br>
6. Cedryl methyl ether 100<br>
7. Cinnamyl cinnamate 50<br>
8. 6,7-Dihydro-1,1,2,3,3-pentamethyl-4(5H)-indanone 20<br>
9. 2-Ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol 50<br>
10. 4-Formyl-2-methoxyphenyl isobutyrate @ 10% in dipropylene glycol 20<br>
11. 16-Hexadec-9-enolide 50<br>
12. 3-frans-lsocamphylcyclohexanol 250<br>
13. Kephalis<br>
(4-(1-ethoxyvinyl)-3,3,5,5-tetramethyl-cyclohexanone and isomers) 1500<br>
14. Linalool 150<br>
15. Methyl dihydrojasmonate 500<br>
16. 3,4-Methylenedioxybenzaldehyde @ 1% in dipropylene glycol (DPG) 50<br>
17. Methyl 2,4-dihydroxy-3,6-dimethylbenzoate 50<br>
18. 6-(1-Methylpropyl)quinoline @ 10% in DPG 50<br>
19. 3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan 10<br>
20. 1,13-Tridecanedioic acid ethylene ester 1000<br>
21. (1R*,4S*,5S*,9R*)-1-Hydroxy-1,4,7,7,9-pentamethyl-spiro[4.5]decan-2-one<br>
@ 10% in dipropylene glycol 5000<br>
Total: 10'000<br>
(1R*,4S*,5S*,9R*)-1-Hydroxy-1,4,7,7,9-pentamethylspiro[4.5]decan-2-one<br>
confers to this woody-ambery, leathery masculine perfume personality and a<br>
sophisticated but natural and characteristic touch of patchouli oil. It harmoniously<br>
blends in with the main woody theme and forms the heart note of this typical note,<br>
without having any unpleasant camphoraceous or dirty impact on the transparent<br>
hesperidic-spicy top note. In comparison with the same amount of patchouli oil, the new<br>
material is stronger, more present and pleasant, and free from a herbal, dirty and<br>
camphoraceous aspects in the top note.<br><br><br><br><br>
We claim<br>
1. A compound of formula (I)<br>
wherein n is 0, 1,2, or 3; and<br>
ring A represents a cycloalkyl ring wherein up to 5 hydrogen atoms are substituted by a methyl<br>
group; and<br>
the total number of carbon atoms of the compound of formula (I) is 1 1, 12, 13, 14, 15, or 16.<br>
2. A compound as claimed in claim 1 wherein the methyl groups at C-1 and C4 are cis- configured<br>
with respect to one another.<br>
3. A compound as claimed in claim 1 selected from the group consisting of<br>
(I P , 4 ~ * , 5 ~ * , 9 P ~ l - h ~ d1r4o17~1-7119 Pentamethy~~P51ird~e[c4a.n -2-one,<br>
(I R",4R*,5S',9R")-l-hydroxy-l,4,7,7,9-pentamethylsp~[4.5]decan-2-one,<br>
(i/?,4Ri)-I-hydroxy-1 ,4,7,7,9,9-hexamethylspiro[4.5]decarr2knel<br>
(1 R*,4S*,5r*,7R',9S?")-1-hydroxy-1,4,7,9-tetramethylspiro[4.5]decan-2-one,<br>
(1~ *,4~*,5r*,7~,9SL)-1-hydroxy-l,4,7,9-tetramethylspiro[4.5]decan-2-onaned,<br>
(1 P,4S*)-l-hydroxy-4,4-dimethylspiro[4.6]undecar1-2-one. .<br>
4. A fragrance composition comprising a compound as claimed in one of the preceding claims.<br>
5. A fragrance application comprising a compound as claimed in claim 1, claim 2 or claim 3.<br>
6. A fragrance application as claimed in claim 5 wherein the fragrance application is selected from<br>
the list consisting of perfUme, household product, laundry product, body care product, cosmetic<br>
product and air-care product.<br>
7. A method of manufacturing a fragrance application, comprising the incorporation of an effective<br>
amount of a compound of formula (I) as defined in claim 1 or claim 2.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUFic3RyYWN0LSgxMy0wNS0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Abstract-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUNsYWltcy0oMTMtMDUtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Claims-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWNvcnJlc3BvbmRlY2Utb3RoZXJzLnBkZg==" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-correspondece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUNvcnJlc3BvbmRlbmNlICBPdGhlcnMtKDEzLTA1LTIwMTMpLnBkZg==" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Correspondence  Others-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWRlc2NyaXB0aW9uIChjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LURyYXdpbmdzLSgxMy0wNS0yMDEzKS5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Drawings-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWRyYXdpbmdzLnBkZg==" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWZvcm0tMS5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUZvcm0tMTgoMTUtMTAtMjAwOCkucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Form-18(15-10-2008).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUZvcm0tMi0oMTMtMDUtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Form-2-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWZvcm0tMi5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-form-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUZvcm0tMy0oMTMtMDUtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Form-3-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWZvcm0tMy5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LWZvcm0tNS5wZGY=" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-form-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LUdQQS0oMTMtMDUtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-GPA-(13-05-2013).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LXBjdC0xMDEucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-pct-101.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LXBjdC0yMTAucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-pct-210.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LXBjdC0yMzcucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-pct-237.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LXBjdC0zMDEucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-pct-301.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LXBjdC0zMDQucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-pct-304.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjY4OS1kZWxucC0yMDA3LVBldGl0aW9uLTEzNy0oMTMtMDUtMjAxMykucGRm" target="_blank" style="word-wrap:break-word;">2689-delnp-2007-Petition-137-(13-05-2013).pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="265184-heteroaromatic-quinoline-compounds.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="265186-method-for-producing-chiral-8-3-amino-piperidin-1-yl-xanthines.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>265185</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2689/DELNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>07/2015</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>13-Feb-2015</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>12-Feb-2015</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>11-Apr-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>GIVAUDAN SA</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>CHEMIN DE LA PARFUMERIE 5, CH-1214 VERNIER,SWITZERLAND</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>PHILIP KRAFT</td>
											<td>KIRCHBACHSTRASSE 4, CH-8600 DUBENDORF, SWITZERLAND</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07C 49/417</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/CH2005/000652</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2005-11-07</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>0424643.5</td>
									<td>2004-11-09</td>
								    <td>U.K.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/265185-spirocyclic-ketols-and-their-use by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 03:45:17 GMT -->
</html>
